跳转至内容
Merck

G5160

Sigma-Aldrich

β 半乳糖苷酶 来源于米曲霉

≥8.0 units/mg solid

别名:

β-D-半乳糖苷半乳糖水解酶, 乳糖酶 来源于米曲霉

登录查看公司和协议定价


About This Item

CAS号:
EC號碼:
MDL號碼:
分類程式碼代碼:
12352204
NACRES:
NA.54

形狀

solid

比活性

≥8.0 units/mg solid

包含

dextrin as extender

儲存溫度

−20°C

正在寻找类似产品? 访问 产品对比指南

相关类别

一般說明

ββ-半乳糖苷酶属于糖苷水解酶clan A(GH-A)家族的一员,广泛存在于包括原核生物和真核生物的微生物中。

應用

β-半乳糖苷酶(来源于米曲霉Aspergillus oryzae)已用于:
  • 体外核磁共振(NMR)
  • 作为β-半乳糖苷酶分析标准品,测定细胞相关的β-半乳糖苷酶浓度
  • 修饰突变滑液细胞(slime cell)表面的糖残基以研究粘附性
  • 乳糖酶促水解实验
  • 反相(RP)吸附实验
  • 乳清乳糖水解

生化/生理作用

ββ-半乳糖苷酶作用于二糖、糖缀合物和多糖末端的β-D-半乳糖基。它可用于介导转糖基反应,比如低聚半乳糖(GOS)合成。ββ-半乳糖苷酶可用于糖生物学和生物技术应用。
β-半乳糖苷酶切割乳糖成单糖成分,葡萄糖和半乳糖。它还能催化葡萄糖转糖基化形成异乳糖,在反馈回路中作为β-半乳糖苷酶的诱导剂。

單位定義

一单位每分钟水解1.0 μmole乳糖,pH4.5,30℃。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Hydrolysis of whey lactose by immobilized β-Galactosidase
Marcela Panaro Mariotti; Hideko Yamanaka; Angela Regina Araujo; Henrique Celso Trevisan
Brazilian Archives of Biology and Technology, 51 (2008)
Modular process for the flexible synthesis of magnetic beads-Process and product validation
Birgit Hickstein1, and Urs Alexander Peuker
Journal of Applied Polymer Science, 112, 2366-2373 (2009)
Jian-Xin Yu et al.
NMR in biomedicine, 21(7), 704-712 (2008-02-22)
Gene therapy has emerged as a promising strategy for treatment of various diseases. However, widespread implementation is hampered by difficulties in assessing the success of transfection in the target tissue and the longevity of gene expression. Thus, there is increasing
A Y Dunina-Barkovskaya et al.
The Journal of membrane biology, 198(2), 77-87 (2004-05-13)
Low gadolinium concentrations induce rapid gigaseal formation and cell adhesion to glass and plastic (polystyrene) substrates in the slime mutant of Neurospora crassa. Cellular adhesion is independent of an integrin-mediated mechanism, because pretreatment with the oligopeptide ARG-GLY-ASP-SER (RGDS) did not
Daniel Muñoz-Espín et al.
EMBO molecular medicine, 10(9) (2018-07-18)
Senescent cells accumulate in multiple aging-associated diseases, and eliminating these cells has recently emerged as a promising therapeutic approach. Here, we take advantage of the high lysosomal β-galactosidase activity of senescent cells to design a drug delivery system based on

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门